Pediatric therapy-related hematologic neoplasms show enrichment for <italic>KMT2A</italic> rearrangement and lymphoblastic phenotype.

MLA

Kovach, Alexandra E., et al. “Pediatric Therapy-Related Hematologic Neoplasms Show Enrichment for KMT2A Rearrangement and Lymphoblastic Phenotype.” Leukemia & Lymphoma, Aug. 2024, pp. 1–13. EBSCOhost, https://doi.org/10.1080/10428194.2024.2376166.

APA

Kovach, A. E., Komova, D., Itov, A., Gaskova, M., Kalinina, I., Voronin, K., Rumiantseva, Y., Karachunskii, A., Maschan, M., Maschan, A., Novichkova, G., Olshanskaya, Y., Bhojwani, D., Raca, G., & Zerkalenkova, E. (2024). Pediatric therapy-related hematologic neoplasms show enrichment for KMT2A rearrangement and lymphoblastic phenotype. Leukemia & Lymphoma, 1–13. https://doi.org/10.1080/10428194.2024.2376166

Chicago

Kovach, Alexandra E., Daria Komova, Albert Itov, Maria Gaskova, Irina Kalinina, Kirill Voronin, Yulia Rumiantseva, et al. 2024. “Pediatric Therapy-Related Hematologic Neoplasms Show Enrichment for KMT2A Rearrangement and Lymphoblastic Phenotype.” Leukemia & Lymphoma, August, 1–13. doi:10.1080/10428194.2024.2376166.